Real world treatment and outcomes in EGFR mutation-positive non-small cell lung cancer: Long-term follow-up of a large patient cohort - ScienceDirect
Clinical characteristics of advanced non-small cell lung cancer patients with EGFR exon 20 insertions | Scientific Reports
Differences among lesions with exon 19, exon 21 EGFR mutations and wild types in surgically resected non-small cell lung cancer | Scientific Reports
EGFR-mutated disease: early combinations and new approaches in exon 20 insertion-positive lung cancer - memoinOncology
Kaplan-Meier survival analysis of patients with NSCLC with or without... | Download Scientific Diagram
An exon 21 L858R EGFR mutation is associated with a decreased survival... | Download Scientific Diagram
Overall survival (OS) curves of EGFR‑mutated patients treated with... | Download Scientific Diagram
Cancers | Free Full-Text | Treatment Strategies for Non-Small Cell Lung Cancer Harboring Common and Uncommon EGFR Mutations: Drug Sensitivity Based on Exon Classification, and Structure-Function Analysis
The prognostic role of EGFR-TKIs for patients with advanced non-small cell lung cancer | Scientific Reports
The different overall survival between single-agent EGFR-TKI treatment and with bevacizumab in non-small cell lung cancer patients with brain metastasis | Scientific Reports
Survival‑associated factors of first‑line EGFR‑tyrosine kinase inhibitor responders and non‑responders in lung adenocarcinoma patients with common EGFR mutations
Cytoplasmic ERβ1 expression is associated with survival of patients with Stage IV lung adenocarcinoma and an EGFR mutation at exon 21 L858R subsequent to treatment with EGFR‑TKIs
10-year long-term survival of a metastatic EGFR-mutated nonsmall cell lung cancer patient | European Respiratory Society
Treatment Options for Non-Small Cell Lung Cancer Harboring Uncommon *EGFR* Mutations | Published in healthbook TIMES Oncology Hematology
Critical Review of *EGFR*-Mutated NSCLC What We Do and Do Not Know | Published in healthbook TIMES Oncology Hematology
Overall survival in advanced epidermal growth factor receptor mutated non-small cell lung cancer using different tyrosine kinase inhibitors in The Netherlands: a retrospective, nationwide registry study - The Lancet Regional Health –
Overall survival in patients with EGFR exon 20 insertions and major... | Download Scientific Diagram
Association between EGFR exon 19 or exon 21 mutations and survival rates after first‑line EGFR‑TKI treatment in patients with non‑small cell lung cancer
THE LIVES AFFECTED BY EGFR EXON 20 INSERTION MUTATIONS
Real-World Survival Outcomes Based on EGFR Mutation Status in Chinese Patients With Lung Adenocarcinoma After Complete Resection: Results From the ICAN Study - JTO Clinical and Research Reports
Kaplan–Meier estimates of overall survival according to EGFR status... | Download Scientific Diagram
Cancers | Free Full-Text | A Nationwide Study on the Impact of Routine Testing for EGFR Mutations in Advanced NSCLC Reveals Distinct Survival Patterns Based on EGFR Mutation Subclasses
Overall survival of EGFR-mutated lung adenocarcinoma patients with or... | Download Scientific Diagram
Survival past five years with advanced, EGFR-mutated or ALK-rearranged non-small cell lung cancer—is there a “tail plateau” in the survival curve of these patients? | BMC Cancer | Full Text
Clinical and molecular characteristics of non-small-cell lung cancer (NSCLC) harboring EGFR mutation: results of the nationwide French Cooperative Thoracic Intergroup (IFCT) program - ScienceDirect
